Maze Therapeutics aims to raise $100 million in an IPO to fund clinical trials for its kidney and related disease treatments.

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

During a ceremony on Friday at TCO Stadium, the festival's 18,148.89-square-foot ice maze with eight-foot-tall walls was ...

One unsung jump scare game in particular pioneered horror in the internet age, blazing everywhere from nascent social media ...

Eagan’s Minnesota Ice Festival is now home to the world's largest ice maze, according to the Guinness World Records ...

A 29-year-old Derry dental technician, James Brendan Moyne, Cable Street, Bogside, died in the early hours of yesterday ...

Check out the Maze Mice reveal teaser trailer for this upcoming time-freezing, mazerunning bullet heaven roguelite game from ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...